A highlight of #organonachip is the power to recapitulate complex, therapeutically-relevant cell interactions. This #video from our Protocol Series shows how cells can be evenly distributed in the media channels or gel-media interface, or preferentially attached to one interface.

Changing culture media mid-experiment is easy on AIM Biotech’s idenTx chips and plates. Check out this video from our Protocol Series showing how simple it can be to work with #organonachip and make your experiments more human-relevant in your lab! aimbiotech.com

The OT-2 lab robot by our friends at Opentrons perfectly showcases how AIM Biotech's idenTx #organonachip can accelerate your in vitro #study using affordable, off-the-shelf lab equipment—while also giving you more human-relevant results. See the video – bit.ly/39ZhJpa

Researchers recently demonstrated the therapeutic potential of STING agonists in combination with NK cell-based #immunotherapy. AIM Biotech's idenTx #drugdiscovery platform was instrumental in some of the key #research assays; check out the science here: bit.ly/3JwfPK3

Developing neuroactive drugs is often inhibited by the human blood-brain barrier (BBB). AIM Biotech tackles this obstacle with a BBB model using our idenTx #organonachip platform—a 3D coculture of pericytes, astrocytes, and endothelial cells. Learn more – aimbiotech.com/applications/b…

Work w/ patient tumor biopsies or tumor #organoids in your #cancerresearch? Wish there was a better way to characterize patient-specific tumor tissue to guide functional #precisionmedicine? We can help—follow AIM Biotech & watch for the October release of our organiX platform!

Want to use the power of #organoids in your #research, but find them hard to work with? Would a system help allowing you to culture immune-competent organoids w/ functional vasculature? And if you could retrieve the organoids for next-gen analyses? October—aimbiotech.com

Today! AIM Biotech is excited to share the release of organiX. Specifically made for #organoids & biopsies, organiX enables the formation of perfusable vasculature & an immune-competent environment—a new level of physiological relevance for #drugdiscovery: bit.ly/3EdMTGm

Check out this article in Genetic Engineering & Biotechnology News on our new organiX platform for #organoids and biopsies: as these types of samples are used more for #drugdiscovery and tumor characterization, creating perfusable vasculature in an immune-competent environment is vital. genengnews.com/topics/transla…

Functional vasculature inside a tissue culture. What does that mean for your #drugdiscovery assays? Is culturing vascularized #organoids or tumor biopsies valuable for functional #precisionmedicine? We think so—learn how organiX can empower your study at aimbiotech.com.

Bridge the gap. Accelerate your research. Dr. Lim Sei Hien from AIM Biotech will host a webinar next month discussing how its organ-on-a-chip platform and the Opentrons OT-2 robot can help scale up assays for #drugdiscovery and #cellbiology #research. insights.opentrons.com/lp/webinar-11-…

Consider an immune-competent environ w/ functional vasculature for your immune-oncology #drugdevelopment. What if it supported human #organoids or biopsy tissue? Our organiX platform can do that. Learn how to humanize your drug dev & clinical decisions @ aimbiotech.com.

Learn how #organonachip platforms & #organoids can bridge the gap between lab cultures and animal studies—tune in to this #webinar! Also see how you can automate your workflow to get more done in your #drugdiscovery & #cellbiology #research. Sign up here! insights.opentrons.com/lp/webinar-11-…

Your work with organoids & tissue biopsy is critical to your #cancerresearch. Leverage the power to add functional vasculature to these tissues w/ organiX. Ready for automation, live imaging, & multi-omics—a revolution in large-sample tissue culture. More: aimbiotech.com

If you missed it—check out our #webinar with our friends at Opentrons. AIM Biotech's Sei Hein Lim discusses how to scale up #drugdiscovery #research w/ AIM’s organiX & idenTx 3D tissue cultures + the Opentrons OT-2 lab robot. Reach out with any questions! vimeo.com/771191080

Functional vasculature is key for in-vitro assays of #cancer treatments. Left: in-vitro immune cells can't enter a tumoroid. Right: in a model powered by AIM Biotech's organiX platform, cells attack a tumoroid's center through human-like vasculature—More @ aimbiotech.com

Check out this pub in Nature Communications from PavesiLab, which includes a 3D cytotoxicity assay based on our idenTx platform. The results suggest a way to boost efficacy of TCR or CAR-based cancer treatment, possibly reducing need for multiple treatment rounds. nature.com/articles/s4146…

We often talk about how the 3D co-culture nature of organ-on-chip assays better mimics the microenvironment of tumors—here, we have a study highlighting that power with melanoma spheroids in a cancer-on-a-chip model based on AIM Biotech's idenTx platform: mdpi.com/2306-5354/10/1…

Combine the power of Nikon Instruments's confocal microscopes with the detail of AIM Biotech's blood-brain barrier (BBB) model: this stunning image comes from a new application note about imaging the BBB in vitro using idenTx #organonachip models. Take a look: bit.ly/3UeHiFF

Big News! AIM Biotech and MatTek Life Sciences are partnering to supply AIM's humanized #OrganOnAChip models for discovery and development of new medicines in North America. Now in MaTek's online store—check out the press release from MatTek and AIM here: aimbiotech.reportablenews.com/pr/mattek-and-…